Novartis is seeking people to participate in a clinical trial(s) testing the safety and effectiveness of Novartis products. Novartis recommends that you consult your doctor before participating in a clinical trial.

For more information about clinical trial participation, click here. Also, for additional information about how Novartis helps to protect the privacy of the personal information that you provide to us, please see the Novartis Privacy Policy.

Please review the details of the clinical trial(s) listed below and click on the one that you feel best suits your (or the participant's) condition.

Kidney Cancer Disease Study CRAD001L2201

The purpose of this clinical research study is to determine the effectiveness of an investigational drug combined with that of an additional drug for participants 18 years of age and older who have metastatic clear cell carcinoma of the kidney (Kidney Cancer). An “investigational drug” is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).